InvestorsHub Logo
Followers 0
Posts 798
Boards Moderated 0
Alias Born 07/27/2018

Re: None

Monday, 12/31/2018 11:10:34 AM

Monday, December 31, 2018 11:10:34 AM

Post# of 41255
Add in the australian human studies as well. We cant forget about those this is bigger than Amedica.

Yet, it is interesting to note that the second study was due to a fungal infection (i.e., Candida albicans). While the effectiveness of Si3N4 against various fungal species is unknown, several recent reports suggest that its antimicrobial behavior may be the result of multivariate mechanisms



This occurs because of the release of minute amounts of silicic acid (Si(OH)4) and ammonia (NH3) into the local biological environment



This is added value for Silicon Nitride spinal.

All Si3N4 variants proved to be superior to PEEK and titanium in resisting bacterial adhesion and biofilm formation



I`m mistaken this studies 2 cases of infection not revision for infection. As a surgeon why risk it? What CTL is now running around with blows the other materials out of the water and makes them obsolete for the low low price of $10 million. I`m still happy for them. We need more crusaders and this hydra sprouted a new head. A head held under private ownership. You can do whatever you got to do to SINT and make it bankrupt, shut it's doors. Put Sonny on the street begging for quarters. It doesn't work now. Chon will keep reviving them like a necromancer with 25%.

Is that a studied defense like crown jewels? if not can we call it the necromancer defense? Well worth the sacrifice in my opinion.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News